Condition: Generalized Anxiety Disorder · Sponsor: Intra-Cellular Therapies, Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in patients meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) criteria for GAD who have an inadequate response to ongoing GAD treatment.
This description comes directly from the study's public registry record.
ITI Clinical Trials · 6464409333 · ITCIClinicalTrials@itci-inc.com
Always discuss trial participation with your own doctor first.
| Clinical Site | Chandler, Arizona, United States | Active Not Recruiting |
| Clinical Site | Encino, California, United States | Recruiting |
| Clinical Site | Glendale, California, United States | Recruiting |
| Clinical Site | Imperial, California, United States | Recruiting |
| Clinical Site | Lemon Grove, California, United States | Recruiting |
| Clinical Site | Oceanside, California, United States | Recruiting |
| Clinical Site | Orange, California, United States | Recruiting |
| Clinical Site | Redlands, California, United States | Recruiting |
| Clinical Site | San Diego, California, United States | Active Not Recruiting |
| Clinical Site | Farmington, Connecticut, United States | Recruiting |
| Clinical Site | Gainesville, Florida, United States | Withdrawn |
| Clinical Site | Lauderhill, Florida, United States | Recruiting |
+ 57 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.